New stroke drug aims to stop clots without causing bleeding
NCT ID NCT06813651
Summary
This study is testing whether adding an experimental drug called TBO-309 improves outcomes for stroke patients undergoing a specific procedure. The drug is given during surgery to open blocked arteries in the neck and brain, with the goal of preventing new clots from forming in the stent without increasing dangerous bleeding. Researchers will enroll 78 patients to see if this approach is safe and helps keep the artery open.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
John Hunter Hospital
RECRUITINGNewcastle, New South Wales, 2305, Australia
Contact Email: •••••@•••••
Contact
-
Royal North Shore Hospital
NOT_YET_RECRUITINGSt Leonards, New South Wales, 2065, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.